Evidence map›Paper›PMID 41397972›Full record

ArticleNature communications2025

Ovarian cancer metastasis to the human omentum disrupts organ homeostasis and induces fundamental tissue reprogramming.

Ulrike Lischetti, Ching-Yeu Liang, Matteo Carrara, Ricardo Coelho, Antoine Hanns, Flavio Lombardo, Arthur Dondi, Sandra Goetze, Michal Hensler, Christian Kurzeder and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. NKG2A inhibition promotes NK cell-CD8Nature communications · 2026
    Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ulrike LischettiUniversity Hospital Basel and University of Basel, Department of Biomedicine, Ovarian Cancer Research, Basel, Switzerland.
Ching-Yeu LiangUniversity Hospital Basel and University of Basel, Department of Biomedicine, Ovarian Cancer Research, Basel, Switzerland.
Matteo CarraraETH Zürich, NEXUS Personalized Health Technologies, Zürich, Switzerland.
Ricardo CoelhoUniversity Hospital Basel and University of Basel, Department of Biomedicine, Ovarian Cancer Research, Basel, Switzerland.ORCID http://orcid.org/0000-0002-9340-3612
Antoine HannsUniversity Hospital Basel and University of Basel, Department of Biomedicine, Ovarian Cancer Research, Basel, Switzerland.
Flavio LombardoUniversity Hospital Basel and University of Basel, Department of Biomedicine, Ovarian Cancer Research, Basel, Switzerland.
Arthur DondiETH Zurich, Department of Biosystems Science and Engineering, Basel, Switzerland.
Sandra GoetzeSIB Swiss Institute of Bioinformatics, Zürich, Switzerland.ORCID http://orcid.org/0000-0001-6880-8020
Michal HenslerSotio Biotech, Prague, Czech Republic.
Christian KurzederUniversity Hospital Basel, Department of Obstetrics and Gynaecology, Basel, Switzerland.
Céline MontavonUniversity Hospital Basel, Department of Obstetrics and Gynaecology, Basel, Switzerland.
Jitka FucikovaSotio Biotech, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-8423-479X
Franziska SingerETH Zürich, NEXUS Personalized Health Technologies, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-6017-1595
Niko BeerenwinkelETH Zurich, Department of Biosystems Science and Engineering, Basel, Switzerland.ORCID http://orcid.org/0000-0002-0573-6119
Christian BeiselETH Zurich, Department of Biosystems Science and Engineering, Basel, Switzerland.ORCID http://orcid.org/0000-0001-5360-2193
Viola Heinzelmann-Schwarz *University Hospital Basel and University of Basel, Department of Biomedicine, Ovarian Cancer Research, Basel, Switzerland.
Francis Jacob *University Hospital Basel and University of Basel, Department of Biomedicine, Ovarian Cancer Research, Basel, Switzerland. francis.jacob@unibas.ch.ORCID http://orcid.org/0000-0002-0446-1942

Funding

Krebsliga Schweiz (Ligue Suisse Contre le Cancer) KFS-5389-08-2021Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 171037Wellcome Trust 220706
6 · The paper itself

Abstract

The omentum, a visceral adipose tissue with critical metabolic, immunological, and stem cell functions is the preferred site for ovarian cancer metastasis. However, its role in maintaining homeostasis and its responses to metastatic colonization remain incompletely understood. Using single-cell transcriptomics, we profile different anatomical regions of the omentum in patients with benign conditions and metastasis. We catalog the benign omentum and observe a stable cell type composition and a preserved stem and progenitor niche. Upon metastatic colonization, we report on increased immune heterogeneity and a concomitant reduction of mesothelial and progenitor cells. The lesser omentum, which is not routinely removed during surgical debulking, is identified as a premetastatic niche characterized by neutrophil infiltration, extracellular trap formation, and the presence of micrometastases. At established metastatic sites, resident cells exhibit cancer-associated phenotypes with regulatory, anti-adipogenic, and immunosuppressive properties. Cellular reprogramming across the omentum is associated with signaling profiles of tumor cells, suggesting potential influences on both proximal and distal tissue regions. This cell atlas illuminates the cellular and molecular determinants of organ homeostasis and reveals a high degree of plasticity and cellular reprogramming promoted by cancer colonization.

Indexed as

Cellular ReprogrammingOmentumOvarian NeoplasmsPeritoneal NeoplasmsFemaleHomeostasisHumansNeoplasm MetastasisSingle-Cell AnalysisTranscriptomeTumor Microenvironment

Identifiers

PMID41397972
PMCPMC12828041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.